reference/20380855

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20380855

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	190
issn	1387-2877 1875-8908
issueIdentifier	1
pageRange	173-190
publicationName	Journal of Alzheimer's disease : JAD
startingPage	173
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd23225bb8277d80089ba14432de98d3 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2724f25c52a80d19857d519216b05966 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_be9ca97bc16e8c6e0bc382382e0f1ac9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_86d8f5af12acba632dda9d0768dfe664 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_70f06442e32280d65bc6d8c4ba22a82f
bibliographicCitation	Dennison JL, Volmar CH, Modarresi F, Ke D, Wang J, Gravel E, Hammond-Vignini S, Li Z, Timmons JA, Lohse I, Hayward MA, Brothers SP, Wahlestedt C. JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model. J Alzheimers Dis. 2022;86(1):173–90. doi: 10.3233/jad-215370. PMID: 35034905.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c53270059db06cda05d396e223325f03 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d57b98b9b49cf80eb756300a10d8696 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3043a2bffa9a13469919b2e819c27935 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_058b5d37ad07aa099ac1375604fc1393 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0fcfc61841a38ecf95cab70e393975e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bcb2304d4f5c96bfa85d82a5e0b679b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c3e8d13c14c1406e0ba8713e74973fa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be00c7a0fb94841c62e1082f67a75bb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ca5a00541e89966ba283ddad3845a5c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ec99ece4b78528e32fae2544fd70145 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc3870516c1442dbb0e9d01a93412897 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3767a2b7d747800c6e0f9aa43780760 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06ebdcd8ecf9a2ef65c4e1ea79c99bab
date	2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3233/jad-215370 https://pubmed.ncbi.nlm.nih.gov/35034905
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 https://portal.issn.org/resource/ISSN/1387-2877 https://portal.issn.org/resource/ISSN/1875-8908
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model1
discusses	http://id.nlm.nih.gov/mesh/M0025678 http://id.nlm.nih.gov/mesh/M0165532 http://id.nlm.nih.gov/mesh/M0205216 http://id.nlm.nih.gov/mesh/M0024885 http://id.nlm.nih.gov/mesh/M0024747
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000544Q000188 http://id.nlm.nih.gov/mesh/D000544Q000235 http://id.nlm.nih.gov/mesh/D000544Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016207Q000235 http://id.nlm.nih.gov/mesh/D008822 http://id.nlm.nih.gov/mesh/D016875Q000378 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D016282 http://id.nlm.nih.gov/mesh/D053829 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000077185
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d6e75560e5588a5e8000b5ba5e20faae http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f8b7e2b439c7244613fadd3c9ea91267 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a22418d761efc2fd7899aa0b2131dbb5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_26affd5ccc17d1026ea8e56bb3df26c8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852

Total number of triples: 65.